Analysts changed outlooks on top stocks. Raymond James downgraded ONON, Deutsche Bank downgraded ATAI, BTIG downgraded APGE.
Five analyst downgrades across biotech and entertainment: On Holding cut to $38 from $52, Legend Biotech to $40 from $75, plus Apogee, AtaiBeckley, and Tencent Music. Cascade signals market rerating on late-stage speculative valuations; material for enterprise tech budget discipline and venture capital allocation skepticism.
Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Raymond James analyst Rick Patel downgraded On Holding AG (NYSE:ONON) from Strong Buy to Outperform and cut the price target from $52 to $38.
On Holding closed at $30.91 on Tuesday.
See how other analysts view this stock.
Wall Street analysts changed ratings on top stocks. Check out the complete list on Benzinga's analyst ratings page. AMAT was…
Top Wall Street analysts changed outlook on top names. View all changes on analyst ratings page. See what analysts think of these…
Top Wall Street analysts changed outlook on top names. Check full changes on analyst ratings page. OKE downgraded.
Top Wall Street analysts changed outlook on top names. See full changes, including upgrades/downgrades/initiations, on analyst…
Wall Street analysts changed outlook on top names, including Alphine Income Property Trust, AAR Corp, and Evommune. See analyst…
Top Wall Street analysts changed outlook on top names. ADCT downgraded See analysts' views.
